United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

kent pharma (uk) ltd - erythromycin - gastro-resistant capsule - 250mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

arrow generics ltd - erythromycin - gastro-resistant capsule - 250mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

phoenix healthcare distribution ltd - erythromycin - gastro-resistant capsule - 250mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

actavis uk ltd - erythromycin - gastro-resistant capsule - 250mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

waymade healthcare plc - erythromycin - gastro-resistant capsule - 250mg

Australia - English - Department of Health (Therapeutic Goods Administration)

mayne pharma international pty ltd - erythromycin, quantity: 250 mg - capsule, modified release - excipient ingredients: lactose monohydrate; monobasic potassium phosphate; povidone; cellacefate; diethyl phthalate; purified water; gelatin; sunset yellow fcf; titanium dioxide; quinoline yellow; erythrosine - indicated in infections due to erythromycin sensitive bacteria: upper & lower respiratory tract infections, sinusitis, otitis media due to streptococcus pyogenes, streptococcus pneumonia. respiratory infections due to mycoplasma pneumonia and haemophylus influenzae (some strains are resistant). legionnaires disease doe to legionella pneumonia. skin infections due to streptococcus pyogenes and staphylococcus aureus.

United States - English - NLM (National Library of Medicine)

mayne pharma inc. - erythromycin (unii: 63937kv33d) (erythromycin - unii:63937kv33d) - erythromycin 250 mg - erythromycin is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the diseases listed below: upper respiratory tract infections of mild to moderate degree caused by streptococcus pyogenes, streptococcus pneumoniae, or haemophilus influenzae (when used concomitantly with adequate doses of sulfonamides, since many strains of h. influenzae are not susceptible to the erythromycin concentrations ordinarily achieved) (see appropriate sulfonamide labeling for prescribing information). lower respiratory tract infections of mild to moderate severity caused by streptococcus pneumoniae or streptococcus pyogenes. listeriosis caused by listeria monocytogenes. pertussis (whooping cough) caused by bordetella pertussis. erythromycin is effective in eliminating the organism from the nasopharynx of infected individuals rendering them noninfectious. some clinical studies suggest that erythromycin may be helpful in the prophylaxis of pertussis in exposed susceptible indivi

India - English - Central Drugs Standard Control Organization

maan - erythromycin estolate - tab - 125mg - 10

India - English - Central Drugs Standard Control Organization

maan - erythromycin estolate - tab - 250mg - 10

India - English - Central Drugs Standard Control Organization

maan - erythromycin estolate - tab - 500mg - 10